Kuwait Thrombosis And Hemostasis Biomarkers Market Size & Outlook
Kuwait thrombosis and hemostasis biomarkers market, 2018-2030 (US$M)
Related Markets
Kuwait thrombosis and hemostasis biomarkers market highlights
- The Kuwait thrombosis and hemostasis biomarkers market generated a revenue of USD 21.6 million in 2022 and is expected to reach USD 29.8 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 4.1% from 2023 to 2030.
- In terms of segment, reagents & consumables was the largest revenue generating product in 2022.
- Analyzers is the most lucrative product segment registering the fastest growth during the forecast period.
Thrombosis and hemostasis biomarkers market data book summary
| Market revenue in 2022 | USD 21.6 million |
| Market revenue in 2030 | USD 29.8 million |
| Growth rate | 4.1% (CAGR from 2022 to 2030) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Analyzers |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Analyzers, Reagents & Consumables |
| Key market players worldwide | BioMerieux SA, Roche Holding AG, Siemens Healthineers AG ADR, Abbott Laboratories, Horiba Ltd, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Biomedica Diagnostics, Werfen, Diazyme Laboratories |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.4% of the global thrombosis and hemostasis biomarkers market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia thrombosis and hemostasis biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 75.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Thrombosis And Hemostasis Biomarkers Market Scope
Thrombosis And Hemostasis Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait thrombosis and hemostasis biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thrombosis and hemostasis biomarkers market will help companies and investors design strategic landscapes.
Reagents & consumables was the largest segment with a revenue share of 65.28% in 2022. Horizon Databook has segmented the Kuwait thrombosis and hemostasis biomarkers market based on analyzers, reagents & consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The key driving factors are the surge in demand for diagnostics tests, which is driven by the increasing prevalence of chronic diseases. Cardiovascular disease is a leading cause of death in Kuwait. In addition, the country has advanced healthcare infrastructure, increasing awareness regarding point of-care testing, and high disposable income.
In addition, initiatives are taken by private and public firms to invest in R&D. Some of the key players in the market are Siemens Healthineers, Abbott Laboratories, and Bio-Rad Laboratories.
Reasons to subscribe to Kuwait thrombosis and hemostasis biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Kuwait thrombosis and hemostasis biomarkers market databook
-
Our clientele includes a mix of thrombosis and hemostasis biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait thrombosis and hemostasis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait thrombosis and hemostasis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Kuwait thrombosis and hemostasis biomarkers market size, by product, 2018-2030 (US$M)
Kuwait Thrombosis And Hemostasis Biomarkers Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
